How Safe is the Blood Supply in the United States?

1990 ◽  
pp. 69-89
Author(s):  
Roger Y. Dodd
PEDIATRICS ◽  
1989 ◽  
Vol 84 (4) ◽  
pp. A24-A24
Author(s):  
J. F. L.

Blood bank officials in the United States are sounding an alarm because they are facing hundreds of lawsuits from people stricken with AIDS after receiving transfusions. Issue of Screening Test The suits generally involve transfusions received before mid-1985, when blood banks started using a screening test that detects antibodies to the AIDS virus in the blood. The central legal issue involves negligence: before the screening test was entirely in place, were the blood banks negligent in their efforts to keep the virus out of the blood supply? The blood banks. . . say the AIDS threat was not fully understood immediately and it was not always clear that the tests would be reliable. Moreover, they say it was often impractical to move more rapidly. While the test has made the nation's blood supply much safer, Federal experts at the Centers for Disease Control in Atlanta estimate that 12,000 people now living in the United States have been infected with the AIDS virus in blood transfusions. Of these, 2,170 adults and 177 children have developed AIDS so far.


2012 ◽  
Vol 3 (2) ◽  
pp. e67-e77
Author(s):  
Christopher S. Hollenbeak ◽  
Matthew Gitlin ◽  
Brian Custer ◽  
William M. McClellan ◽  
Axel Hofmann ◽  
...  

2004 ◽  
Vol 80 (4) ◽  
pp. 301-305 ◽  
Author(s):  
Roger Y. Dodd

2021 ◽  
pp. e1-e7
Author(s):  
William Riley ◽  
Kailey Love ◽  
Jeffrey McCullough

The COVID-19 pandemic has precipitated an acute blood shortage for medical transfusions, exacerbating an already tenuous blood supply system in the United States, contributing to the public health crisis, and raising deeper questions regarding emergency preparedness planning for ensuring blood availability. However, these issues around blood availability during the pandemic are related primarily to the decline in supply caused by reduced donations during the pandemic rather than increased demand for transfusion of patients with COVID-19. The challenges to ensure a safe blood supply during the pandemic will continue until a vaccine is developed, effective treatments are available, or the virus goes away. If this virus or a similar virus were capable of transmission through blood, it would have a catastrophic impact on the health care system, causing a future public health emergency that would jeopardize the national blood supply. In this article, we identify the impact of the COVID-19 pandemic on blood supply adequacy, discuss the public health implications, propose recovery strategies, and present recommendations for preparing for the next disruption in blood supply driven by a public health emergency. (Am J Public Health. Published online ahead of print March 18, 2021: e1–e7. https://doi.org/10.2105/AJPH.2021.306157 )


Transfusion ◽  
2000 ◽  
Vol 40 (10) ◽  
pp. 1165-1168 ◽  
Author(s):  
Susan L. Stramer ◽  
Sally Caglioti ◽  
D.M. Strong

Transfusion ◽  
1997 ◽  
Vol 37 (2) ◽  
pp. 237-241 ◽  
Author(s):  
RG Westphal

Transfusion ◽  
2009 ◽  
Vol 49 (5) ◽  
pp. 895-902 ◽  
Author(s):  
Francis Vekeman ◽  
Brahim K. Bookhart ◽  
Joshua White ◽  
R. Scott McKenzie ◽  
Mei Sheng Duh ◽  
...  

Transfusion ◽  
2014 ◽  
Vol 54 (7) ◽  
pp. 1903-1904 ◽  
Author(s):  
Garrett S. Booth ◽  
Eric A. Gehrie

Sign in / Sign up

Export Citation Format

Share Document